· Published by Health Canada · Official notice
This is duplicated text of a letter from Hospira Healthcare Corporation.
Contact the company for a copy of any references, attachments or enclosures.
Notice about Health Canada advisories
March 7, 2011
Dear Healthcare Professional:
Please distribute to relevant Departments (Surgery, Emergency Medicine, Pharmacy, Paediatrics, Anaesthesia, Geriatrics, Internal Medicine, Nursing, Intensive Care and/or other Departments as required), and other involved professional staff and post this Notice in your institution.
Subject: UPDATE: Recall of all Plum A+ Infusion Pumps due to audible alarm failure
| Product | List Number |
|---|---|
| Plum A+ Hyperbaric Infusion Pump | 11005 |
| Plum A+ Infusion Pump | 12391 |
| Plum A+3 Infusion Pump | 12618 |
| Plum A+3 with Hospira MedNet Software | 20678 |
| Plum A+ with Hospira MedNet Software | 20679 |
| Plum A+ Driver | 20792 |
This is an update to our communication dated February 14, 2011. Following several inquiries received from customers regarding the test method recommended by Hospira in the previous communication, Hospira has validated an alternate method to perform the audible alarm test. This new method does not require the use of a dry cassette and may be used in place of the original test method described.
Note that this test will identify if the alarm has already failed. However, even if a pump successfully passes this test, this does not guarantee that the alarm will not fail during the next clinical use.
To perform the test:
Hospira personnel will provide additional training support as needed to ensure staff members have a clear understanding of the alarm test procedure. Please contact your Hospira representative to request training support.
Hospira is developing a design improvement to resolve this issue. Validation of this solution for all device configurations is in progress. Once the redesign activities are complete and inventory is available, Hospira will notify customers to schedule replacement of the buzzer assemblies.
Please complete the attached Reply Form and return it via fax to the number on the form.
Managing marketed health product-related adverse incidents depends on health care professionals and consumers reporting them. Reporting rates determined on the basis of spontaneously reported post-market adverse incidents are generally presumed to underestimate the risks associated with health product treatments. Any cases of alarm failure or other serious or unexpected adverse incidents for medical devices in patients using Plum A+ Infusion Pumps should be reported to Hospira, Inc. or Health Canada at the following addresses:
Hospira Healthcare Corporation
1111 Dr. Frederik-Philips Blvd
Saint-Laurent, Quebec
H4M 2X6
Any suspected adverse incident can also be reported to:
Health Products and Food Branch Inspectorate
HEALTH CANADA
Address Locator: 2003D
Ottawa, Ontario K1A 0K9
Telephone: The Inspectorate Hotline 1-800-267-9675
The Medical Devices Problem Report Form and Guidelines can be found on the Health Canada Web site.
For other medical device inquiries related to this communication, please contact Health Canada at:
Marketed Health Products Directorate
E-mail: mhpd_dpsc@hc-sc.gc.ca
Telephone: 613-954-6522
Fax: 613-952-7738
To change your mailing address or fax number, contact the Market Authorization Holder (Industry).
Sincerely,
original signed by
Beryl Chan
Regional Director, Quality & Regulatory Affairs
This HTML document is not a form. Its purpose is to display the information as found on the form for viewing purposes only. If you wish to use the form, you must use the alternate format below.
RESPONSE REQUIRED
No Audible Alarm (March 7, 2011)
PLUM A+™ Family of Infusers
COMPLETE THE INFORMATION AND FAX THE COMPLETED FORM TO 1-877-906-0208.
Business Name
Address/City/Province/Postal code
Hospira Customer Number (if applicable)
Contact Name
Contact Phone/e-mail Address
Completed by: Printed Name/Signature/Date